MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
equity securities, net
$18,614,135
Net cash provided by
financing activities
$18,014,135
Canceled cashflow
$600,000
Net change in cash
and cash...
$194,753
Canceled cashflow
$17,819,382
Payment of amounts due to
officers
$600,000
Increase (decrease) in
accounts payable and...
$1,325,128
Stock based
compensation
$1,147,236
Amortization of intangibles
$100,000
Proceeds from redemption
of investments
$7,986,294
Net cash used in
operating activities
-$13,540,994
Net cash used by
investing activities
-$4,277,775
Effect of foreign
exchange rate on changes...
-$613
Canceled cashflow
$2,572,364
Canceled cashflow
$7,986,294
Net loss
-$15,804,655
Purchase of investments
$12,264,069
Realized and unrealized
gain and accrued...
$215,855
Decrease in prepaid
expenses and other assets
$92,848
Back
Back
Cash Flow
source: myfinsight.com
Quoin Pharmaceuticals, Ltd. (QNRX)
Quoin Pharmaceuticals, Ltd. (QNRX)